Emily A. Voigt

This study evaluates a TB vaccine candidate, ID93 + GLA-3M-052-LS, showing enhanced mucosal and systemic immunity and protection against Mtb in BCG-primed mice.

This paper demonstrates the successful spray drying of a replicon-NLC vaccine against H5N1 avian influenza, maintaining stability and immunogenicity for up to 3 months at 4°C.

This paper develops a bivalent self-amplifying RNA vaccine against yellow fever and Zika viruses, showing it induces robust immune responses and complete protection in animal models.

This paper develops a replicon vaccine against H5N1 influenza that can be administered intranasally or intramuscularly, showing efficacy in reducing morbidity and mortality in a ferret model.

An intranasal self-amplifying RNA vaccine delivered via nanostructured lipid carriers induces mucosal immunity and protects against H5N1 and H7N9 influenza in ferrets.